Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3113 results found
Expand All
Apply All
3113 results found

Inquiry Form for United Van Lines
Share
BIO Business Solutions
BIO Business Solutions® is the largest cost savings purchasing program for the biotech industry operated by the Biotechnology Innovation Organization (BIO). With more than half a billion in annual sales, BIO Business Solutions® aggregates the purchasing power of over 4,700 life science companies from North America. Companies of all sizes save substantial money each year through this cost-savings program. To request information for the BIO-United Van Lines Program, please fill the fields below and click the Submit button at the bottom of the form.   MktoForms2.loadForm("//app-ab15.marketo.com", "490-EHZ-999", 3893);
Read More

VICP, Colorado PDAB, and AMR
Share
Good Day BIO Newsletter  •  August 7, 2023
This week is off to a busy start, with the House introducing bills to strengthen the Vaccine Injury Compensation Program, Colorado’s PDAB taking action, and an important discussion on AMR and amputees. (834 words, 4 minutes, 10 seconds)
Read More

CDC recommends RSV mAb for all infants
Share
Good Day BIO Newsletter  •  August 4, 2023
A busy news Friday: CDC advisors voted to recommend the routine use of the first approved monoclonal antibody for RSV in infants, and a new poll shows voters like agricultural biotech and want faster regulatory approvals. (528 words, 2 minutes, 38 seconds)
Read More

Majority of U.S. Voters Support Streamlined Biotech Regulations
Share
Press Release  •  August 3, 2023
New BIO/Morning Consult survey shows strong support for biotech innovation and its role in addressing critical global challenges.The majority of U.S. voters (62%) hold a favorable opinion of biotechnology and view its benefits as important, according to new survey data. The poll, conducted by Morning Consult on behalf of the Biotechnology Innovation Organization (BIO), also finds strong support for streamlining regulatory processes and updating government policies to allow innovative technologies to come to market.Two-thirds (66%) of voters agree that the government’s regulatory approval process should be updated to allow agricultural biotechnology companies to commercialize innovative products more quickly. A  study last year found that the time it takes to get new biotech plant traits to market has increased 21% since 2012 and the regulatory phase is the longest part of the process of commercializing new traits.A similar share, 67%, of registered voters support government policies that seek to address the country’s challenges, including food insecurity and climate change, through biotechnology.“Voters are eager to leverage cutting-edge biotechnology solutions to address some of the world’s biggest challenges. These survey findings should signal to policymakers the importance of advancing regulatory clarity to help bring biotechnology products to market,” said BIO Vice President for Agriculture & Environment Beth Ellikidis. “It’s time for the administration to put policy action behind its vision. There is a desparate need for the holistic approach outlined in the Biden administration’s ‘Bold Goals for U.S. Biotechnology and Biomanufacturing’ to harness biotechnology in achieving societal goals — such as furthering agricultural innovation, creating food supply resilience, and developing climate change solutions.”Voters surveyed ranked the most important benefits of agricultural and industrial biotechnology as: increasing crop yields to produce more food…
Read More

BIO Finance & Tax Committee Meeting
Share
August 3, 2023
The Committee concentrates on tax, financial services, securities, and accounting policies that impact member companies and biotech capital formation. This committee advises BIO staff about the impact of legislation and regulations affecting these policy matters and supports BIO’s engagement with Treasury, the SEC, and the IRS, as well as Congress and the Administration. For more information and to join the Committee, please contact Emily Berst (eberst@bio.org).
Read More

BIO Comments to FDA on Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products
Share
Letters, Testimony & Comments  •  August 3, 2023
In response to the agency's request for information (Docket No. FDA-2023-N-0743-0002), BIO provides detailed comments.
Read More

Imaginative approaches to cancer
Share
Good Day BIO Newsletter  •  August 3, 2023
We have profiles of three cancer innovators—and why it matters in the context of recent policy developments. Plus, the Pantheon Awards are accepting nominations until August 11 and NIH announced Dr. Fauci’s successor. (476 words, 2 minutes, 22 seconds)
Read More

340B needs reform, says BIO
Share
Good Day BIO Newsletter  •  August 2, 2023
BIO recently submitted comments to the U.S. Senate on the 340B program—here’s what we said, plus a recap of a successful BIO Asia-Taiwan. (406 words, 2 minutes, 1 second)
Read More

BIO Comments on the NIH Technology Transfer Workshop
Share
Food & Farm Innovation  •  Letters, Testimony & Comments  •  August 1, 2023
BIO provides detailed comments in advance of the July 31, 2023 NIH Workshop, “Transforming Discoveries into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer.
Read More

Preserving the value of public/private partnerships
Share
Good Day BIO Newsletter  •  August 1, 2023
Happy August. BIO’s Dr. Hans Sauer explains exactly who funds biotech R&D, and a tick-borne allergy is on the rise as temperatures change ticks’ habits. (653 words, 3 minutes, 15 seconds)
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 86
  • 87
  • 88
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO